Cargando…
Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy
PURPOSE: Fibroblast activation protein (FAP) is a membrane-bound protease that has limited expression in normal adult tissues but is highly expressed in the tumor microenvironment of many solid cancers. FAP-2286 is a FAP-binding peptide coupled to a radionuclide chelator that is currently being inve...
Autores principales: | Zboralski, Dirk, Hoehne, Aileen, Bredenbeck, Anne, Schumann, Anne, Nguyen, Minh, Schneider, Eberhard, Ungewiss, Jan, Paschke, Matthias, Haase, Christian, von Hacht, Jan L., Kwan, Tanya, Lin, Kevin K., Lenore, Jan, Harding, Thomas C., Xiao, Jim, Simmons, Andrew D., Mohan, Ajay-Mohan, Beindorff, Nicola, Reineke, Ulrich, Smerling, Christiane, Osterkamp, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399058/ https://www.ncbi.nlm.nih.gov/pubmed/35608703 http://dx.doi.org/10.1007/s00259-022-05842-5 |
Ejemplares similares
-
Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using (177)Lu-FAP-2286: First-in-Humans Results
por: Baum, Richard P., et al.
Publicado: (2022) -
Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition
por: Zboralski, Dirk, et al.
Publicado: (2023) -
2286 A CTSA External Reviewer Exchange Consortium: Description and lessons learned
por: Schneider, Margaret, et al.
Publicado: (2018) -
PReS-FINAL-2286: Mastitis in an adolescent patient with juvenile systemic lupus erythematous
por: Bica, BE, et al.
Publicado: (2013) -
Increasing molar activity by HPLC purification improves (68)Ga-DOTA-NAPamide tumor accumulation in a B16/F1 melanoma xenograft model
por: von Hacht, Jan Lennart, et al.
Publicado: (2019)